Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.



At this time, we are not accepting new case inquiries.

Naproxen Side Effects May Lead To Heart Attack Lawsuits

Naproxen | Lawsuits, Lawyers | Side Effects: Heart Attacks, Cardiovascular Problems

A recent Government study showed that the painkiller Naproxen, sold as Aleve, can cause an increased risk of heart attacks and other cardiovascular problems. The FDA said patients taking naproxen, which is also sold generically should not exceed the recommended dose and should not take it for more than 10 days unless directed by their doctor.

The researchers noticed a 50 percent increased risk of cardiovascular events in naproxen patients. In all, 70 patients in the trial experienced heart attacks or strokes, out of a total of 2,500 people. There were about 23 deaths.

Naproxen has been on the market as a prescription drug since 1976 and as a lower-dose, over-the-counter drug (Aleve) since 1994.

Legal Hep For Victims Of Naproxen

To contact us at Parker Waichman LLP fill out form to the right or Call us at 1-800-YOURLAWYER (1-800-968-7529).


NaproxenRSS Feed

Study Links NSAIDs to Higher Risk of Death from Endometrial Cancer

Feb 6, 2017
Study Looks at Drugs Like Aspirin, Ibuprofen and Cancer-Related Death Patients who regularly use non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may have a higher risk of dying from Type 1 endometrial cancers, a study published in the Journal of the National Cancer Institute suggests. Lead researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) conducted a...

Safety of Painkillers

They were hailed as wonder drugs, stopping pain without side effects, but their claims turned out to be too good to be true. Up next, the story the pain these painkillers brought to one family.COSTELLO: For months we've heard sometimes conflicting reports on the safety of painkillers, such as Vioxx or Celebrex. Beginning tomorrow, the FDA will hold hearings on the risks and benefits of the drugs and to see if they're safe enough to sell.More now from CNN medical correspondent Dr. Sanjay...

Banned Report On Vioxx Published

Jan 25, 2005 | Financial Times
A report on Vioxx risks previously blocked by the Food and Drug Administration was published online Monday after the agency withdrew its opposition.The study found that as many as 140,000 cases of heart disease in the United States and as many as 56,000 deaths were caused by the painkiller during the five years that it was on the market.The study’s findings were announced in August at a medical meeting in France and in a Nov. 18 Senate hearing by its lead author, Dr. David J....

A Rudderless, Leaderless FDA

Jan 18, 2005 | Los Angeles Times
James Guest is president of Consumers Union, which publishes Consumer Reports; Marvin M. Lipman MD is chief medical advisor at Consumers Union.It's been a rough time for the Food and Drug Administration. Daily revelations about the potentially serious side effects of nationally known pain relievers Vioxx, Paxil, Celebrex, Aleve, Bextra have cast doubt over the agency's ability to ensure drug safety. Those doubts were reinforced in November when the agency's...

Editorial | Vioxx, Celebrex and Aleve

Dec 23, 2004 | Philadelphia Inquirer
Major drugmakers are having a run of bad luck that could make for a sequel to the box-office hit Lemony Snicket's A Series of Unfortunate Events but for the fact that this is no mock-Gothic story line, and that real-life patients' health is at risk.Merck & Co.'s arthritis pain medicine Vioxx is off the market after studies cited an increased risk of heart problems. Pfizer Inc. this week halted advertising for its popular pain-reliever Celebrex on the same grounds.New warning labels are due...

More Naproxen News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo